Ehrlichiosis associated vasculitis

Journal of Internal Medicine

Volumn 247, Issue 6, 2000, Pages 674-678

  Pick, N ^a   Potasman, Israel ^a   Strenger, C ^b   Keysary, A ^b   Schwartz, I ^c  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

E. chaffeensis; Human granulocytic ehrlichiosis agent; PCR; Serology

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SKIN BIOPSY; VASCULITIS;

ADULT; ANTIBODIES, BACTERIAL; BIOPSY; DIAGNOSIS, DIFFERENTIAL; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYARTERITIS NODOSA; POLYMERASE CHAIN REACTION; PURPURA, SCHOENLEIN-HENOCH; RETROSPECTIVE STUDIES; SKIN; VASCULITIS;

EID: 0033922480     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00680.x     Document Type: Article

References (29)

1. 1 Fauci A. The Vasculitis Syndromes. In: Fauci A, Braunwald E, Isselbacher K, Wilson J, Martin J, Kasper D, Hauser S, Longo D, eds. Harrison's Principles of Internal Medicine 14 Ed, Vol 2 New York, USA: McGraw-Hill, 1998: 1910-22.
2. 2 Sergent J. Lockshin M, Christian C, Gocke D. Vasculitis with hepatitis B antigenemia: long term observation in nine patients. Med 1976; 55: 1-18.
3. 3 Guillevin L. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchange. Ann Rheum Dis 1994; 53: 334.
4. 4 Agnello V, Chung R, Kaplan L. A role for hepatitis C virus infection in type 2 cryoglobulinemia. N Eng J Med 1992; 327: 1490-5.
5. 5 Somer T, Finegold S. Vasculitis associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 1995; 20: 1010.
6. 6 Everett E, Evans K, Henry R, McDonald G. Human ehrlichiosis in adults after tick exposure. ANN Intern Med 1994; 120: 730-5.
7. 7 Dumler J, Bakken J. Ehrlichial diseases of humans: Emerging tick-borne infections. Clin Infect Dis 1995; 20: 1102-10.
8. 8 Roland W, McDonald G, Caldwell C, Everett E. Ehrlichiosis - a cause of prolonged fever. Clin Infect Dis 1995; 20: 821-5.
9. 9 Nicholson W, Comer J, Sumner J, Gingrich-Baker C, Coughlin R, Magnarelli L, et al. An indirect immunofluorescent assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1997; 35: 1510-6.
10. 10 Schwartz I, Varde S, Nadelman R, Wormer G, Fish D. Inhibition of efficient polymerase chain reaction amplifucation of Borrelia Burgdorferi DNA in blood-fed ticks. Am J Trop Med Hyg 1997; 56: 339-42.
11. 11 Sumner J, Nicholson W, Massung R. PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol 1997; 35: 2087-92.
12. 12 Walker D, Dumler J. Emerging and re-emerging rickettsial diseases. N Eng J Med 1994; 24: 1651-2.
13. 13 Baneth G, Waner T, Koplah A, Weinstein S, Keysary A. Survey of Ehrlichia canis antibodies among dogs in Israel. Vet Rec 1996; 138: 257-9.
14. 14 Keysary A, Amram L, Rzotkiewicz S, Strenger C, Waner T. The diagnosis of rickettsial diseases in Israel. In: 13th Sesqui-Annual Meeting of the ASR Champion, PA, 1997.
15. 15 Munke H, Stockmann F, Ramadori G. Possible association between Behcet's syndrome and chronic hepatitis C virus infection. N Engl J Med 1995; 332: 400-1 (letter).
16. 16 Zhou Y, Leon M, Waclawiw M, Popma J, Yu Z, Finkel T, Epstein S. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335: 624-30.
17. 17 Libman B, Quismorio F, Stimmler M. Polyarteritis nodosalike vasculitis in human immunodeficiency virus infection. J Rheumatol 1995; 22: 351-5.
18. 18 Genereau T, Wechsler B, Frances C, Godeau P. Cutaneous vasculitis during Chlamydia trachomatis seroconversion. Br J Dermatol 1995; 132: 1022-3(letter).
19. 19 Kiptoon J, Mugera G. Invasion of capillary endothelial cells by Ehrlichia ondiri. Vet Rec 1983; 112: 59-60.
20. 20 Grant A, Hunter S, Partin W. A case of acute monocytic ehrlichiosis with prominent neurologic signs. Neurol 1997; 48: 1619-23.
21. 21 Marty A. Ehrlichiosis mimicking thrombotic thrombocytopenic purpura. Case report and pathological correlation. Hum Pathol 1995; 26: 920-5.
22. 22 George F, Brouqui P, Boffa M, Mutin M, Drancourt M, Brisson C, et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993; 82: 2109-16.
23. 23 Dumler J, Gage W, Pettis G, Azad A, Kuhadja F. Rapid immunoperoxidase demonstration of Rickettsia rickettsii in fixed cutaneous specimen from patients with Rocky Mountain spotted fever. Am J Clin Pathol 1990; 93: 410-4.
24. 24 Potasman I, Bassan H. Pulmonary embolism complicating murine typhus. J Roy Soc Med 1986; 79: 367-8.
25. 25 Linnemann J, Pretzman C, Peterson E. Acute febrile cerebrovasculitis. A non-spotted fever group rickettsial disease. Arch Intern Med 1989; 149: 1682-4.
26. 26 Fishbein D, Dawson J, Robinson. L. Human ehrlichiosis in the United States. 1985-90. Ann Inter Med 1994; 120: 736-43.
27. 27 Klein M, Nelson C, Goodman J. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother 1997; 41: 76-9.
28. 28 Autio P, Keski O. Tetracyclines as anti inflammatory treatment in skin diseases. Nord Med 1996; 10: 348.
29. 29 Toussior E, Despaux J, Wendling D. Do minocycline and tetracycline have a place in rheumatology? Rev Rheum 1997; 64: 474-80.